Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Werte in diesem Artikel
For the quarter ended September 2025, Kamada (KMDA) reported revenue of $47.01 million, up 12.6% over the same period last year. EPS came in at $0.09, compared to $0.07 in the year-ago quarter.The reported revenue represents a surprise of +1.64% over the Zacks Consensus Estimate of $46.25 million. With the consensus EPS estimate being $0.10, the EPS surprise was -10%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Kamada performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Distribution: $7.49 million compared to the $5.45 million average estimate based on three analysts. The reported number represents a change of +62.3% year over year.Revenues- Proprietary products: $39.52 million compared to the $40.8 million average estimate based on three analysts. The reported number represents a change of +6.5% year over year.Gross Profit- Distribution: $1.12 million versus the three-analyst average estimate of $0.99 million.Gross Profit- Proprietary products: $18.64 million compared to the $18.81 million average estimate based on three analysts.View all Key Company Metrics for Kamada here>>>Shares of Kamada have returned -2.1% over the past month versus the Zacks S&P 500 composite's +0.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kamada Ltd. (KMDA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Kamada
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Kamada
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Kamada Ltd
Analysen zu Kamada Ltd
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.2018 | Kamada Buy | Chardan Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.2018 | Kamada Buy | Chardan Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Kamada Ltd nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen